Shire Ends Patent War With Actavis, Watson Over ADHD Drug
A unit of pharmaceutical giant Shire PLC said Thursday that it had reached a settlement with Actavis Inc. and Watson Pharmaceuticals Inc., resolving all pending patent litigation over the companies' attempts...To view the full article, register now.
Already a subscriber? Click here to view full article